KRASG12C-positive NSCLC and CRC
Two-dose, inactivated vaccine
The vaccine is easily distributed and stored.
The efficacy remains to be determined, with rates as low as 50% reported by Brazil, but the vaccine can reportedly reduce the need for hospitalization and the most severe forms of COVID-19 by 100%.
Access our global intelligence, advanced analytics and global team of experts.